<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02085902</url>
  </required_header>
  <id_info>
    <org_study_id>CHD 079-13</org_study_id>
    <nct_id>NCT02085902</nct_id>
  </id_info>
  <brief_title>Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?</brief_title>
  <acronym>VesiRop</acronym>
  <official_title>Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the recommendations of the French Society of Digestive Surgery 2010, cholecystectomy&#xD;
      can be performed as outpatient surgery. This approach is difficult in many centers because of&#xD;
      post operative pain and nausea/vomiting.&#xD;
&#xD;
      The use of postoperative morphine may be responsible for the state of nausea. The use of&#xD;
      ropivacaine allows a reduction of the morphine consumption and thus may allow the patient to&#xD;
      have their surgery as an outpatient.&#xD;
&#xD;
      Currently, ropivacaine is used randomly during the investigators surgeries. Initially, it was&#xD;
      used for the infiltration holes trocar. In recent years, ropivacaine is used for the&#xD;
      reduction of intra-abdominal postoperative pain. Its use is made of parietal surgery ( hernia&#xD;
      ) in cholecystectomy and colonic surgery. This mode of administration is allowed to view the&#xD;
      many publications made on this subject. Its use in the investigators daily surgery, however,&#xD;
      has not been evaluated in ambulatory surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to discharge patient after surgery</measure>
    <time_frame>6 hours postoperative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cholecystectomy</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>standard anesthesia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>standard anesthesia with ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>standard anesthesia with ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Programmed Cholecystectomy&#xD;
&#xD;
          -  Laparoscopy&#xD;
&#xD;
          -  Man and woman&#xD;
&#xD;
          -  ≥ 18&#xD;
&#xD;
          -  ASA 1 or 2&#xD;
&#xD;
          -  Not living alone&#xD;
&#xD;
          -  Patient receiving social security coverage&#xD;
&#xD;
          -  Signature of Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cholecystectomy emergency&#xD;
&#xD;
          -  Patient minor&#xD;
&#xD;
          -  Pregnant woman (pregnancy test) or during breastfeeding&#xD;
&#xD;
          -  Conversion to laparotomy&#xD;
&#xD;
          -  Patient anticoagulant curative dose&#xD;
&#xD;
          -  Living alone&#xD;
&#xD;
          -  Patient addict&#xD;
&#xD;
          -  Peptic Ulcer&#xD;
&#xD;
          -  Refusal to enter the protocol&#xD;
&#xD;
          -  Chronic requiring analgesics long-term&#xD;
&#xD;
          -  Immunosuppression&#xD;
&#xD;
          -  Long-term Treatment with corticosteroids&#xD;
&#xD;
          -  Discovery intraoperative calculation in the bile duct&#xD;
&#xD;
          -  Contraindication to ropivacaine (see cons-indications to ropivacaine)&#xD;
&#xD;
          -  Hypersensitivity to study treatment or concomitant medications anesthesia&#xD;
&#xD;
          -  Cardiac or unbalanced epileptic patients (due to the risk of cardiovascular and&#xD;
             neurological local anesthetics)&#xD;
&#xD;
          -  Patients ASA ≥ 3&#xD;
&#xD;
          -  Patient &lt;50 kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emeric ABET, Dr</last_name>
    <role>Study Director</role>
    <affiliation>CHD Vendée La Roche sur Yon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier départemental Vendée</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>March 7, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>May 18, 2015</last_update_submitted>
  <last_update_submitted_qc>May 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

